Business · 04/10/2005Updated: 10/17/2026 · 1 min read
FDA Opens Public Workshop on Rare Plasma Protein Disorders for Public Comment
The FDA is seeking public input on the development of treatments for rare plasma protein disorders, following a 2005 workshop, and is making workshop presentations available for review.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →